NanoVibronix Ltd. aus Nesher auf der MEDICA 2018 in Düsseldorf -- COMPAMED Messe

NanoVibronix Ltd.

9 Derech Hashalom St., 36651 Nesher
Telefon +972 4 8200581
Fax +972 4 8202794

Dieser Aussteller ist Mitaussteller von
Israel Export & International Cooperation Institute


MEDICA 2018 Hallenplan (Halle 16): Stand G40


MEDICA 2018 Geländeplan: Halle 16

Unser Angebot


  • 01  Elektromedizin / Medizintechnik
  • 01.04  Therapie und Physikalische Medizin
  • 01.04.08  Ultraschalltherapiegeräte


Unsere Produkte

Produktkategorie: Ultraschalltherapiegeräte

PainShield; UroShield; WounShield

PainShield TM - ultrasound therapy for pain relief, soft tissue healing and non-union fractures.

UroShield TM - diminishes biofilm formation on urinary catheters and prevents UTI, increases antibiotic efficacy and decreases pain and discomfort associated with urinary catheter use.

WoundShield TM - increases tissue oxygenation for accelerated healing of chronic and acute wounds.

Recent interim results of UroShield study demonstrate efficacy preventing catheter-acquired urinary tract infections -

Less than 4% using UroShield developed infections versus 52% of control group

Mehr Weniger

Über uns


NanoVibronix is a medical device company that fulfills significant unmet medical needs in the therapeutic areas of pain, wound and soft tissue healing as well as in catheter related infections.

NanoVibronix Ltd. performs R&D, manufacturing and marketing of its products and is a subsidiary of NanoVibronix Inc. - located in Elmsford, NY. 

The company is publicly traded in NASDAQ (NAOV).

NanoVibronix’s technology consists of a unique, miniature transducer technology that transmits low-frequency, low-intensity ultrasound onto treatment surface. These small, thin and lightweight transducers create Surface Acoustic Waves reaching up to 10 cm from the transducer. These unique properties allow the creation of a small, self-adhering acoustic patch that contains the transducer and administers the ultrasound. This application revolutionizes the administration ultrasound for therapeutic clinical applications, encouraging patients' independence; promoting clinician supervised home based care and reducing the cost of therapy. Applications using this technology include pain, soft tissue healing and wound treatment.

The technology allows converting indwelling catheters into active acoustic disease-fighting devices. Certain catheters often pose a risk of biofilm and infection as well as a risk of trauma and discomfort. NanoVibronix devices attached to catheters reduce catheter-acquired infection, antibiotic usage and bacterial resistance and therapeutically treat catheter-associated injury.

Mehr Weniger